Ken Sugimoto

19PUBLICATIONS
8CO-AUTHORS
PharmacogenomicsMolecular targetsCharacterisation of biological macromoleculesRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 10, 2026
Effect of Low-Dose Vonoprazan on Hepatic Cytochrome P450 Activity By 13C-Aminopyrine Breath Test in Healthy Subjects.

|Oct 03, 2025
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury.

Chiemi Ema, Takamasa Iwakura, Naoko Tsuji

|May 21, 2025
Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional Study.

Natsuki Ishida, Satoshi Tamura, Tomohiro Takebe

|Apr 12, 2024
Ustekinumab effectiveness in Crohn's disease with lesions in the intestines.

Satoshi Tamura, Yusuke Asai, Natsuki Ishida

|Jan 02, 2024
Albumin change predicts failure in ulcerative colitis treated with adalimumab.

Natsuki Ishida, Kenichi Takahashi, Yusuke Asai

|Oct 03, 2023
Efficacy and safety of risankizumab for Crohn's disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies.

Xiang Gao, Toshimitsu Fujii, Byong Duk Ye

Pageof 4

Frequent Collaborators

1 joint publications

Jen-Wei Chou

1 joint publications

Chiemi Ema

1 joint publications

Takamasa Iwakura

1 joint publications

Naoko Tsuji